Recent Quotes (30 days)

You have no recent quotes
chg | %

Wi-LAN Inc.  

(Public, TSE:WIN)   Watch this stock  
Find more results for WIN
3.73
+0.21 (5.97%)
Oct 31 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 3.53 - 3.75
52 week 3.16 - 4.35
Open 3.59
Vol / Avg. 792,784.00/340,006.00
Mkt cap 448.27M
P/E 72.04
Div/yield 0.05/5.36
EPS 0.05
Shares 120.28M
Beta 1.19
Inst. own     -
Oct 29, 2014
Q3 2014 WiLan Inc Earnings Conference Call (Tentative)
Oct 29, 2014
Q3 2014 WiLan Inc Earnings Release (Tentative)
Sep 18, 2014
WiLan Inc at CIBC Eastern Institutional Investor Conference
Sep 4, 2014
WiLan Inc at Liolios Group Gateway Conference
Aug 14, 2014
WiLan Inc at Canaccord Genuity Growth Conference
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 21.82% -20.51%
Operating margin 34.40% -21.43%
EBITD margin - 67.15%
Return on average assets 6.64% -5.42%
Return on average equity 8.82% -6.64%
Employees 63 -
CDP Score - -

Address

Suite 608, 11 Holland Avenue
OTTAWA, ON K1Y 4S1
Canada
+1-613-6884900 (Phone)
+1-613-6884894 (Fax)

Website links

Description

WiLAN Inc. (WiLAN), is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world. As of December 31, 2011, it had a portfolio of approximately 3,000 patents, including issued and pending patents and foreign equivalents. In June 2013, it acquired a portfolio of patents from Cypress Semiconductor Corporation. In November 2013, it acquired a portfolio of semiconductor patents from IXYS CH GmbH related to microcontroller technology. In June 2014, the Company announced that a subsidiary has acquired a portfolio of medical patents that relate to Stent technology.

Officers and directors

W. Paul McCarten Independent Chairman of the Board
Age: 69
James Douglas Skippen President, Chief Executive Officer, Chief Legal Officer, Director
Age: 51
Michael Shaun McEwan Chief Financial Officer
Kenneth Stanwood President of Cygnus Broadband, Inc.
Michael B. Vladescu Chief Operating Officer
Andrew Parolin Senior Vice President - Licensing
Mark Schneider Senior Vice President, Business Unit Leader and Senior Patent Counsel
Doug MacCrae Vice President - Finance
Prashant Watchmaker Vice President - Corporate Legal & Corporate Secretary
Marc Frechette Vice President, Business Unit Leader and Senior Patent Counsel